SILENSEED
Silenseed is a clinical stage biopharmaceutical company that develops proprietary RNA interference (RNAi)-based cancer drugs and delivery systems designed to effectively penetrate and treat malignant solid tumors. The company’ novel drugs, used together with the new delivery system, the LODER™ (LOcal Drug EluteR), have the potential to be one of the most highly effective treatments for solid tumor cancers. Diseases that currently are included in the company’s pipeline are pancreatic cancer, prostate cancer and certain brain cancers.
SILENSEED
Industry:
Biopharma Biotechnology Health Care Therapeutics
Founded:
1999-01-01
Address:
Jerusalem, Yerushalayim, Israel
Country:
Israel
Website Url:
http://www.silenseed.com
Total Employee:
1+
Status:
Active
Contact:
972 2 674 3430
Email Addresses:
[email protected]
Total Funding:
10.5 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics
Similar Organizations
Aclaris Therapeutics
Aclaris Therapeutics is a specialty pharmaceutical company engaged in developing dermatologic therapies.
Chiasma
Chiasma is a biopharmaceutical company developing oral drugs for the treatment of orphan diseases.
Civitas Therapeutics
Civitas Therapeutics is a biopharmaceutical company that focuses on developing pulmonary delivery therapies.
Cytovant
Cytovant is a biopharmaceutical company focused on developing novel and innovative cellular therapeutics.
immatics biotechnologies
immatics is a biopharmaceutical company focused on the development of immunotherapeutic substances for cancer therapy.
Innovent Biologics
Innovent Biologics is a biopharmaceutical company that develops and manufactures monoclonal antibodies.
Kind Pharmaceutical
Kind Pharmaceutical is a clinical-stage biopharmaceutical company that focuses on the discovery and development of anemia drugs.
MiReven
MiReven is a biopharmaceutical company focused on developing miR-7 as a cancer therapy.
Positive Sequence Biology
Positive Sequence Biology is a biotech company with new gene system-based editing, focused on biotech innovation & breakthrough therapies.
SiNOPSEE Therapeutics
SiNOPSEE THERAPEUTICS Pvt Ltd is a bio-pharmaceutical company focused on the discovery, design.
Sinovac Biotech
Sinovac Biotech Ltd. is a China-based biopharmaceutical company that focuses on research, development, manufacturing and commercialization
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Spark Therapeutics
Spark Therapeutics is focused on the development of gene therapy.
Zensun (Shanghai) Sci & Tech Co.
a biopharmaceutical company focusing on the development of innovative bio-therapeutic.
Current Employees Featured
Founder
Investors List
Laursen van Swieten
Laursen van Swieten investment in Series A - Silenseed
Official Site Inspections
http://www.silenseed.com
- Host name: mail.stepup.co.il
- IP address: 80.244.169.125
- Location: Israel
- Latitude: 31.5
- Longitude: 34.75
- Timezone: Asia/Jerusalem
More informations about "Silenseed"
Home - Silexion
D- Dr Gabai Malka Joined Silenseed in February 2009 and leads the development of the formulation and the production of the KRAS-LODER from the concept stage and up to Phase II. Dr Gabai Malka holds a B.Sc. in Chemistry …See details»
Silenseed - Funding, Financials, Valuation & Investors - Crunchbase
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Dec 1, 2020: Series A - …See details»
Silenseed Company Profile - Office Locations, Competitors ... - Craft
Silenseed is a biopharmaceutical company developing RNA interference (RNAi)-based cancer drugs. It offers drugs used together with the delivery system, the LODER (LOcal Drug EluteR), …See details»
Silenseed - VentureRadar
" Silenseed LTD is a clinical stage biopharmaceutical company that is developing proprietary RNA interference (RNAi)-based cancer drugs and delivery systems designed to effectively …See details»
Silenseed - Contacts, Employees, Board Members, Advisors
Organization. Silenseed . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 1. About. Silenseed has 1 …See details»
Silenseed - Products, Competitors, Financials, Employees, …
Silenseed was founded in 2008. Where is Silenseed's headquarters? Silenseed's headquarters is located at Modi’in Technology Park, Modi'In. What is Silenseed's latest funding round? …See details»
Silenseed CEO and Key Executive Team | Craft.co
Silenseed's Director is Ilan Shiloah. Other executives include Len Potter, Chairman ; Yaniv Zilber, Director and 1 others. See the full leadership team at Craft.See details»
Silenseed - CB Insights
Silenseed's latest funding round was a Unattributed - II for $7.8M on October 25, 2021. Date. Round. Amount. Investors. Valuation. Valuations are submitted by companies, mined from …See details»
Silenseed signs $7.8 million agreement with GIBF to create ... - ctech
Oct 5, 2021 Silenseed is a biopharmaceutical company developing RNA interference (RNAi)-based cancer drugs and delivery systems. Diseases that currently are included in the …See details»
Silenseed - Updates, News, Events, Signals & Triggers - Crunchbase
Apr 8, 2014 Organization. Silenseed . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Recent News & Activity. Edit Recent News …See details»
Silenseed - Targeted Therapies for Solid Tumors - YouTube
Silenseed is currently conducting a global phase 2 clinical trial for treating stage 3 pancreatic cancer to find out more follow this website https://panca...See details»
Israel's Silenseed Raises $7.8 Million for China RNAi Joint Venture
Oct 25, 2021 Silenseed, a Tel Aviv RNAi company, raised $7.8 million from the Guangzhou Sino-Israel Bio-Industry Investment Fund to start a China JV. Silenseed-China will own the …See details»
Silexion Therapeutics Presented the LODER™ phase 2 summary …
Oct 30, 2023 D- Dr Gabai Malka Joined Silenseed in February 2009 and leads the development of the formulation and the production of the KRAS-LODER from the concept stage and up to …See details»
Silenseed seeks $36.4M IPO to develop RNAi-based cancer drugs
Silenseed Ltd. followed hot on the heels of Vascular Biogenics Ltd. (VBL) to become the fourth Israeli biotech this year to seek a listing on a U.S. exchange. Filing as an emerging growth …See details»
Silenseed - Crunchbase
Silenseed, Civitas Therapeutics, Aclaris Therapeutics, Innovent Biologics, Soligenix, and Zensun (Shanghai) Sci & Tech Co. are all part of the biopharmaceutical industry. Civitas Therapeutics …See details»
Silenseed Files for $36.4M IPO as it Nears Phase II Trial for ...
Jul 3, 2014 Silenseed has not yet identified therapeutic targets for this program, but has made strides with the delivery technology. "Distribution of drug within the entire tumor is a long …See details»
Silenseed Publishes Data on siRNA Delivery System, Plans
Dec 5, 2013 Israeli RNAi drug developer Silenseed this week published in vitro and in vivo data demonstrating the potential of its implantable siRNA delivery system to knock down the …See details»
Silenseed - Tech Stack, Apps, Patents & Trademarks - Crunchbase
Organization. Silenseed . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ... Silenseed uses 13 technology products and services …See details»
Silenseed cans Nasdaq IPO as RNAi-cancer pitch fizzles
Nov 12, 2015 Silenseed has formally scrapped its plan to list on Nasdaq. The developer of RNAi-based cancer drugs pitched up on Wall Street more than one year ago with a view to …See details»